Huons Global Co. Ltd (084110) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huons Global Co. Ltd (084110) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩22.89 Billion ≈ $15.51 Million USD) by net assets (₩1.04 Trillion ≈ $701.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huons Global Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Huons Global Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Huons Global Co. Ltd (084110) financial obligations for a breakdown of total debt and financial obligations.
Huons Global Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huons Global Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Duta Pertiwi Tbk
JK:DUTI
|
0.009x |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
0.056x |
|
Texmaco Rail & Engineering Limited
NSE:TEXRAIL
|
0.073x |
|
Top Gum Industries Ltd
TA:TPGM
|
0.020x |
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
N/A |
|
Minto Apartment Real Estate Investment Trust
TO:MI-UN
|
0.017x |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
0.020x |
|
Changsha Tongcheng Holdings Co Ltd
SHE:000419
|
0.081x |
Annual Cash Flow Conversion Efficiency for Huons Global Co. Ltd (2010–2025)
The table below shows the annual cash flow conversion efficiency of Huons Global Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Huons Global Co. Ltd (084110) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩1.09 Trillion ≈ $739.51 Million |
₩93.61 Billion ≈ $63.44 Million |
0.086x | -55.64% |
| 2024-12-31 | ₩520.11 Billion ≈ $352.47 Million |
₩100.57 Billion ≈ $68.16 Million |
0.193x | +76.15% |
| 2023-12-31 | ₩910.68 Billion ≈ $617.15 Million |
₩99.97 Billion ≈ $67.75 Million |
0.110x | -19.15% |
| 2022-12-31 | ₩464.32 Billion ≈ $314.66 Million |
₩63.04 Billion ≈ $42.72 Million |
0.136x | +46.56% |
| 2021-12-31 | ₩537.84 Billion ≈ $364.49 Million |
₩49.82 Billion ≈ $33.76 Million |
0.093x | -57.79% |
| 2020-12-31 | ₩412.83 Billion ≈ $279.77 Million |
₩90.59 Billion ≈ $61.39 Million |
0.219x | +26.73% |
| 2019-12-31 | ₩378.53 Billion ≈ $256.52 Million |
₩65.55 Billion ≈ $44.42 Million |
0.173x | +17.42% |
| 2018-12-31 | ₩362.21 Billion ≈ $245.47 Million |
₩53.42 Billion ≈ $36.20 Million |
0.147x | +5.87% |
| 2017-12-31 | ₩341.14 Billion ≈ $231.19 Million |
₩47.52 Billion ≈ $32.20 Million |
0.139x | +129.81% |
| 2016-12-31 | ₩319.80 Billion ≈ $216.72 Million |
₩19.38 Billion ≈ $13.14 Million |
0.061x | -79.89% |
| 2015-12-31 | ₩168.94 Billion ≈ $114.49 Million |
₩50.91 Billion ≈ $34.50 Million |
0.301x | +97.16% |
| 2014-12-31 | ₩188.38 Billion ≈ $127.66 Million |
₩28.79 Billion ≈ $19.51 Million |
0.153x | -22.72% |
| 2013-12-31 | ₩125.24 Billion ≈ $84.87 Million |
₩24.77 Billion ≈ $16.79 Million |
0.198x | +2.71% |
| 2012-12-31 | ₩92.92 Billion ≈ $62.97 Million |
₩17.89 Billion ≈ $12.13 Million |
0.193x | +125.39% |
| 2010-12-31 | ₩78.18 Billion ≈ $52.98 Million |
₩6.68 Billion ≈ $4.53 Million |
0.085x | -- |
About Huons Global Co. Ltd
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more